Although we found congruent molecular signatures of anti-TNF treatment in our combined analysis of IBD patients, entity-specific analyses and feature selection results raise the notion that for further translation into clinical studies, distinct sets of markers might be needed for each IBD subentity. Here, TNF is linked to inflammatory bowel disease.